You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

E2006

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Sleep Apnea, Obstructive, Pulmonary Disease, Chronic Obstructive, Respiration Disorders Trial in United States (Placebo,

Completed
  • Sleep Apnea, Obstructive
  • +2 more
  • Placebo
  • Lemborexant 10 mg
  • Glendale, Arizona
  • +10 more
Feb 15, 2022

Safety of DAYVIGO (Lemborexant) Tablets in Insomnia.

Completed
  • Sleep Initiation and Maintenance Disorders
  • Nagoya, Japan
  • +2 more
Apr 4, 2022

Healthy Volunteers Trial in Las Vegas (Lemborexant)

Completed
  • Healthy Volunteers
  • Las Vegas, Nevada
    PPD Phase 1 Clinic
Sep 2, 2021

Healthy Volunteer Trial in Shanghai (Lemborexant)

Completed
  • Healthy Volunteer
  • Shanghai, China
    Xuhui Central Hospital
Jul 13, 2021

Sleep Initiation and Maintenance Disorders Trial in Korea, Republic of (Lemborexant, PBO)

Recruiting
  • Sleep Initiation and Maintenance Disorders
  • Seongnam-si, Gyeonggi-do, Korea, Republic of
  • +8 more
Dec 20, 2022

Advanced or Recurrent Solid Tumors, FGFR Gene Alterations Trial in Japan (E7090)

Recruiting
  • Advanced or Recurrent Solid Tumors
  • FGFR Gene Alterations
  • Aoba-ku, Sendai, Miyagi, Japan
  • +4 more
May 9, 2022

Sleep Initiation and Maintenance Disorders Trial in China, Taiwan (Lemborexant, Placebo)

Recruiting
  • Sleep Initiation and Maintenance Disorders
  • Beijing, Beijing, China
  • +24 more
Feb 1, 2023

Insomnia Trial in New York, Cincinnati (E2006 1.0 mg, E2006 2.5 mg, E2006 5.0 mg)

Completed
Has Results
  • Insomnia
  • E2006 1.0 mg
  • +10 more
  • New York, New York
  • +1 more
Jan 3, 2020

Insomnia Trial in United States (LEM 5 mg, LEM 10 mg)

Completed
Has Results
  • Insomnia
  • LEM 5 mg
  • LEM 10 mg
  • Glendale, Arizona
  • +16 more
Mar 17, 2021

Insomnia Disorder Trial in Atlanta, Crestview Hills (Lemborexant 5 mg, Lemborexant 10 mg, Lemborexant-matched .)

Completed
Has Results
  • Insomnia Disorder
  • Lemborexant 5 mg
  • +3 more
  • Atlanta, Georgia
  • +1 more
Jan 3, 2020

Hepatic Impairment Trial in Miami, Orlando (Lemborexant)

Completed
Has Results
  • Hepatic Impairment
  • Miami, Florida
  • +1 more
Mar 3, 2020

Renal Impairment Trial in Miami, Orlando (Lemborexant)

Completed
Has Results
  • Renal Impairment
  • Miami, Florida
  • +1 more
Mar 3, 2020

Insomnia Disorders Trial in Toronto (Zolpidem tablets, Suvorexant tablets, over-encapsulated, Lemborexant tablets)

Completed
  • Insomnia Disorders
  • Zolpidem tablets
  • +5 more
  • Toronto, Canada
    INC Research Toronto, Inc.
Jun 26, 2020

Chronic Insomnia, Adults, Elderly Trial in United States (E2006, Placebo)

Completed
Has Results
  • Chronic Insomnia
  • +2 more
  • E2006
  • Placebo
  • Glendale, Arizona
  • +28 more
Jan 22, 2020

Advanced Pancreatic Cancer Trial in Worldwide (IMM-101, Gemcitabine)

Completed
Has Results
  • Advanced Pancreatic Cancer
  • Nicosia, Strovolos, Cyprus
  • +20 more
Nov 3, 2021

Influenza A Trial in Worldwide (Low dose of VIS410, High dose of VIS410, Placebo)

Completed
Has Results
  • Influenza A
  • Low dose of VIS410
  • +2 more
  • Tucson, Arizona
  • +113 more
Dec 9, 2022

Eczema, Atopic Dermatitis Trial in Worldwide (KY1005, Placebo)

Active, not recruiting
  • Eczema
  • Atopic Dermatitis
  • Fremont, California
  • +102 more
Dec 13, 2022

Alzheimer's Disease Trial in Worldwide (Semorinemab, Placebo, [18F]GTP1)

Terminated
Has Results
  • Alzheimer's Disease
  • Birmingham, Alabama
  • +132 more
Feb 16, 2022

Obesity, Cardiovascular Diseases Trial in Worldwide (Retatrutide, Placebo)

Not yet recruiting
  • Obesity
  • Cardiovascular Diseases
  • Phoenix, Arizona
  • +165 more
May 22, 2023

Endometrial Tumors Trial in Worldwide (pembrolizumab, carboplatin, paclitaxel)

Recruiting
  • Endometrial Neoplasms
  • pembrolizumab
  • +4 more
  • Miami Beach, Florida
  • +106 more
Aug 11, 2022

Triple Negative Breast Tumors Trial in Worldwide (Pembrolizumab, Carboplatin, Paclitaxel)

Active, not recruiting
  • Triple Negative Breast Neoplasms
  • Pembrolizumab
  • +7 more
  • Scottsdale, Arizona
  • +192 more
Jul 8, 2022

Type 2 Diabetes Trial in Worldwide (Ertugliflozin 5 mg, Ertugliflozin 15 mg, Placebo)

Recruiting
  • Type 2 Diabetes Mellitus
  • Ertugliflozin 5 mg
  • +4 more
  • Birmingham, Alabama
  • +99 more
Nov 25, 2022

Insomnia Trial in Worldwide (Lemborexant, Lemborexant-matched , Zolpidem tartrate)

Completed
Has Results
  • Insomnia
  • Jasper, Alabama
  • +101 more
Jan 31, 2020

Healthy Subjects Trial in Toronto (Lemborexant, Alcohol, Placebo)

Completed
  • Healthy Subjects
  • Toronto, Ontario, Canada
    Syneos Health
Oct 16, 2018

HER2-negative Breast Cancer, Triple Negative Breast Cancer Trial in France, Germany, Ireland (Capecitabine, Carboplatin,

Recruiting
  • HER2-negative Breast Cancer
  • Triple Negative Breast Cancer
  • Brasschaat, Belgium
  • +161 more
Nov 2, 2022